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Abstract
The SMILES trial was the first intervention study to test dietary improvement as a treatment strategy for depression.
Molendijk et al. propose that expectation bias and difficulties with blinding might account for the large effect size.
While we acknowledge the issue of expectation bias in lifestyle intervention trials and indeed discuss this as a key
limitation in our paper, we observed a strong correlation between dietary change and change in depression scores,
which we argue is consistent with a causal effect and we believe unlikely to be an artefact of inadequate blinding.
Since its publication, our results have been largely replicated and our recent economic evaluation of SMILES
suggests that the benefits of our approach extend beyond depression. We argue that the SMILES trial should be
considered an important, albeit preliminary, first step in the field of nutritional psychiatry research.
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Dear editor
We appreciate the interest that Drs Molendijk, Fried
and van der Does [1] have shown in our recently pub-
lished SMILES study [2]. Drs Molendijk and colleagues’
concerns highlight the methodological complexity inher-
ent in nutrition research (and lifestyle and behavioural
medicine more broadly) as compared to other areas of
medical research. Within the framework of a conven-
tional randomised controlled study design, we attempted
to address these methodological constraints in the devel-
opment and execution of the trial.
Expectation bias is a key issue associated with
non-pharmacotherapeutic-based intervention studies, in-
cluding nutrition, physical activity and many psycho-
therapeutic trials. Our ethics committees were
intractable on the issue of concealing our hypotheses; in-
deed, our previous research in the field of nutrition and
mental health had already received much high-profile
media coverage both locally and nationally. We acknowl-
edged the possibility of expectation bias as the primary
limitation in our study. We also acknowledged the lim-
ited sample size and the difficulties we had in recruiting
participants. We would like to address some further
points in regard to the authors’ concerns.
 The use of a website, media, or advertisements to
seek a positive effect. Use of a website, media or
advertisements is a common recruitment strategy
utilised in community-based trials. Our recruitment
website was not initiated until the latter stages of
the trial (June 2014, 2 years after study recruitment
commenced), after which we recruited only 12 more
participants. Of these, only one reported the website
as their recruitment point. Use of a website, media
or advertisements to deliberately and selectively seek
a positive effect would have been a poor strategy; ex-
pectation bias that may have arisen from our re-
cruitment materials would have affected both active
and control conditions. While we were concerned
about the possibility of expectation bias in those
eventually randomised to the dietary condition, we
were equally, if not more, concerned with the poten-
tial for contamination of the psychosocial support
control condition—an evidence-based supported
comparison of known benefit. It is well recognised
that one of the main challenges in conducting life-
style interventions relates to the fact that those in
the control condition also often make changes and
improvements to their lifestyles, based on the
* Correspondence: f.jacka@deakin.edu.au
1IMPACT Strategic Research Centre, Deakin University, Geelong, VIC, Australia
2Centre for Adolescent Health, Murdoch Children’s Research Institute,
Parkville, VIC, Australia
Full list of author information is available at the end of the article
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Jacka et al. BMC Medicine          (2018) 16:237 
https://doi.org/10.1186/s12916-018-1228-y
expectation of benefit [3]. As such, our recruitment
materials would have been as least as likely to dilute
the main effects of the intervention, creating a bias
towards the null hypothesis.
 The fruity smiley face (https://dietdepressionstudy.com/)
and the local newspaper article to which Molendijk et
al. [1] refer were from media interviews. The extensive
observational literature in this field that predated and
provided the rationale for the SMILES trial had
already received very extensive coverage in both the
Australian and international media. Thus, the idea
that a healthy diet may be of benefit in patients with
depression was widely understood by the public prior
to the trial, and well before either that single article or
our website. Three human research and ethics
committees approved our study, including our media
communications plans, materials and media
interviews.
 Molendijk et al. [1] query our primary outcome, the
“interviewer-rated Montgomery–Åsberg Depression
Rating Scale (MADRS)”. In fact, this is the gold-
standard tool for assessing depressive symptoms in
clinical trials and is the most widely used outcome
measure. It is true that all subjective outcomes are
sensitive to expectancy and hence may overestimate
the effect. One of the acknowledged difficulties in
psychiatry research is the lack of biomarkers or ob-
jective measures of mental health. As such, we are
all restricted to the use of clinical assessments. This
is a generic limitation of our trial and all others in
the field. Including an active control with previous
evidence of benefit is the best way to try and address
this issue, and this is what we did. As reported in
our original paper, all three mental health measures
showed improvement in the diet group, relative to
controls. We regard the correlation between changes
in the modified Mediterranean diet score and
MADRS in the intervention group as being consist-
ent with a causal effect.
 Loss of blinding in our study is a possibility and we
agree that a loss of blinding will bias towards a
bigger effect. However, we made considerable efforts
to conceal group allocation from independent blind
raters who were formally trained in the
administration of the MADRS.
 The dropout rate was higher in the befriending
group, which may be a random finding, a marker of
efficacy differential or a function of the trial design
that is common to behavioural, psychological and
lifestyle medicine trials. We confirm that we
conducted thorough sensitivity analyses to examine
the impact of non-random dropouts. The sensitivity
analysis assumed dropouts were correlated with bet-
ter outcomes in the control group and worse
outcomes in the intervention group. Our findings
withstood even extreme assumptions about the po-
tential impact of non-random dropouts. Again, the
nature of dropouts and potential biases were thor-
oughly addressed in our original manuscript.
Additional file 1: Table S1 provides data on the
characteristics of those who completed the follow-
up and dropouts according to allocation groups.
Encouraging insights from our study were that partici-
pants were able to make positive changes to their diet,
despite their illness, and that these improvements were
correlated with improvements in depressive symptoms.
Furthermore, qualitative feedback from participants re-
vealed that the support and education from a dietician
was highly valuable in helping participants make sus-
tained improvements to their diet and, accordingly, their
mental health. Undoubtedly, further efficacy and effect-
iveness trials in this space are warranted to refine and
develop this approach, both for the betterment of people
with depression as well as for scientific advancement.
As the first randomised controlled trial of its type, we
openly acknowledge the limitations of our study and the
field in general [4]. However, these limitations were thor-
oughly addressed in the original manuscript to the satis-
faction of the reviewers and the journal, and we believe
our trial should be considered an important, albeit pre-
liminary, first-step in this field. In this regard, we would
note that the findings of the SMILES study have now
been largely replicated—an essential next step in the sci-
entific process. The HELFIMED study employed a
group-based intervention with a larger sample size
(n=152), producing very similar findings to ours [5]. In
both studies, the degree of dietary change correlated
closely with the degree of improvement in depression
symptoms. Further, the recent economic evaluation of
our trial suggests large cost savings for our approach [6].
Taken together, these data may support broader imple-
mentation of this approach to depression management
in the future.
Additional file
Additional file 1: Table S1. Comparing baseline characteristics of all
those randomised to the dietary support (DS) and social support (SS)
groups according to dropout status. (DOCX 23 kb)
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